Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 8/20 | 0.38 |
| ▸ | RXRB | P28702 | 7/20 | 0.38 |
| ▸ | RARB | P10826 | 12/20 | 0.36 |
| ▸ | RARG | P13631 | 12/20 | 0.36 |
| ▸ | RARA | P10276 | 10/20 | 0.36 |
| ▸ | RXRG | P48443 | 5/20 | 0.34 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.33 |
| ▸ | WRN | Q14191 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7931979 | 0.81 | RARB (0.36) | RXRARXRBRARBRARGRARA | |
| SCHEMBL7929418 | 0.81 | RARB (0.50) | RXRARXRBRARBRARGRARA | |
| SCHEMBL7929520 | 0.80 | RXRA (0.42) | RXRARXRBRARBRARGRARA | |
| SCHEMBL7922809 | 0.78 | RXRA (0.43) | RXRARXRBRARBRARGRARA | |
| SCHEMBL7949397 | 0.76 | CYP26A1 (0.34) | RXRARXRBRARBRARGRARA | |
| SCHEMBL7929435 | 0.76 | RXRA (0.32) | RXRARXRBRARBRARGRARA | |
| SCHEMBL7931062 | 0.75 | RXRA (0.40) | RXRARXRBRARBRARGRARA | |
| SCHEMBL7949336 | 0.74 | RXRA (0.69) | RXRARXRBRARBRARGRARA | |
| SCHEMBL7922980 | 0.70 | RXRA (0.36) | RXRARXRBRARBRARGRARA | |
| SCHEMBL7922977 | 0.70 | RXRA (0.36) | RXRARXRBRARBRARGRARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0879223-B1 | AROMATIC POLYCYCLIC RETINOID-TYPE DERIVATIVES, METHOD FOR PREPARING SAME, AND USE THEREOF FOR MAKING PHARMACEUTICAL AND COSMETIC COMPOSITIONS | CT EUROP DE BIOPROSPECTIVE CEB (FR) | 2001-11-07 | — | — | EP | disclosed |
| US-6265423-B1 | SKIN DISORDERS; ANTICANCER AGENTS | CENTRE EUROPEEN DE BIOPROSPECTIVE-CEB (FR) | 2001-07-24 | — | — | US | disclosed |